Compare DCTH & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCTH | RGR |
|---|---|---|
| Founded | 1988 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.4M | 601.9M |
| IPO Year | 2015 | 1994 |
| Metric | DCTH | RGR |
|---|---|---|
| Price | $16.31 | $38.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $22.00 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 686.8K | 98.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | ★ 107.53 | N/A |
| EPS | 0.04 | ★ 0.44 |
| Revenue | N/A | ★ $546,057,000.00 |
| Revenue This Year | $24.54 | $2.38 |
| Revenue Next Year | $33.15 | N/A |
| P/E Ratio | $412.00 | ★ $84.39 |
| Revenue Growth | N/A | ★ 1.94 |
| 52 Week Low | $8.12 | $28.33 |
| 52 Week High | $17.42 | $48.21 |
| Indicator | DCTH | RGR |
|---|---|---|
| Relative Strength Index (RSI) | 59.15 | 42.61 |
| Support Level | $9.98 | $36.73 |
| Resistance Level | $17.42 | $38.99 |
| Average True Range (ATR) | 0.45 | 0.86 |
| MACD | -0.19 | -0.04 |
| Stochastic Oscillator | 30.65 | 5.91 |
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.